Keigo Tsujimoto

Executive Vice President (HQ)
Chairman & CEO, Linical Europe

Keigo Tsujimoto

Our project approach and processes are tailored to meet the specific needs

Our project approach and processes are tailored to meet the specific needs

Linical Europe is headquartered in Germany (Frankfurt) with substantial presence in France (Paris) and Spain (Madrid). Our geographic footprint facilitates a significant presence in the leading Western European markets combined with well-established operations in key markets in Central and Eastern Europe.

Linical prides itself on a strong track record in all phases of drug development. Our project approach and processes are tailored to meet the specific needs of your trial. Our Medical Affairs Division features access to several full time medics with broad therapeutic experience.

Maximum transparency throughout each study

Maximum transparency throughout each study

Linical’s Corporate Data Management and Biostatistics teams are based in Madrid, Spain. Our Data Science Center offers tailored concepts across all key therapeutic areas with particular expertise in early Phase I/II studies. Moreover, pivotal Phase II/III trials are supported, but also late-phase approaches such as observational studies, post approval studies (PAS) and post authorization safety studies (PASS), to serve global as well as regional and national projects.
We thrive for efficient solutions that are helping our clients. We work as integrated teams functioning with maximum transparency throughout each study, making sure that the client is kept up to date on progress and all study parameters.
Our quality assurance system supports every aspect of our activities and ensures our deliverables are fully compliant with international and local regulations.